We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Patterson Companies (PDCO) Q1 Earnings: What's in Store?
Read MoreHide Full Article
Patterson Companies Inc (PDCO - Free Report) is set to report first-quarter 2017 results on Aug 25, before the opening bell. Last quarter, the company reported adjusted earnings of 77 cents per share from continuing operations, beating the Zacks Consensus Estimate by a penny.
However, the four-quarter trailing average surprise came negative at 4.21%.
Let’s see how things are shaping up prior to this announcement.
Factors at Play
We believe a growing and diversified product portfolio, strong veterinary business prospects, accretive acquisitions and strategic partnerships are key catalysts for the company.
Exclusively, the partnership of Patterson Companies with Sirona in bringing high-tech CEREC units to dental groups registered with American Dental Partners is likely to help the company gain market traction.
We are also highly optimistic about the lucrative opportunities in the companion-animal and production animal segment. The company is expected to primarily benefit from improving end markets which would drive top-line growth over the long haul.
However, our proven model does not conclusively show that Patterson Companies is likely to beat earnings this quarter. That is because a stock needs to have both a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) for this to happen. That is not the case here as you will see below.
Zacks ESP: Patterson Companies currently has an Earnings ESP of -3.92%. This is because the Most Accurate estimate stands at 49 cents while the Zacks Consensus Estimate remains at 51 cents.
Zacks Rank: Patterson Companies currently carries a Zacks Rank #4 (Sell). Please note that we caution against stocks with a Zacks Rank #4 or 5 (Sell-rated) going into the earnings announcement, especially when the company is seeing negative estimate revision.
Stocks to Consider
Here are some companies you may want to consider as our model shows they have the right combination of elements to post an earnings beat this quarter:
Best Buy Co., Inc (BBY - Free Report) with an Earnings ESP of +4.76% and a Zacks Rank #3.
Ascendis Pharma A/S Inc. (ASND - Free Report) with an Earnings ESP of +7.46% and a Zacks Rank #2.
Broadcom Limited (AVGO - Free Report) with an Earnings ESP of +0.87% and a Zacks Rank #3.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
Unique Zacks Analysis of Your Chosen Ticker
Pick one free report - opportunity may be withdrawn at any time
Image: Bigstock
Patterson Companies (PDCO) Q1 Earnings: What's in Store?
Patterson Companies Inc (PDCO - Free Report) is set to report first-quarter 2017 results on Aug 25, before the opening bell. Last quarter, the company reported adjusted earnings of 77 cents per share from continuing operations, beating the Zacks Consensus Estimate by a penny.
However, the four-quarter trailing average surprise came negative at 4.21%.
Let’s see how things are shaping up prior to this announcement.
Factors at Play
We believe a growing and diversified product portfolio, strong veterinary business prospects, accretive acquisitions and strategic partnerships are key catalysts for the company.
Exclusively, the partnership of Patterson Companies with Sirona in bringing high-tech CEREC units to dental groups registered with American Dental Partners is likely to help the company gain market traction.
We are also highly optimistic about the lucrative opportunities in the companion-animal and production animal segment. The company is expected to primarily benefit from improving end markets which would drive top-line growth over the long haul.
PATTERSON COS Price and EPS Surprise
PATTERSON COS Price and EPS Surprise | PATTERSON COS Quote
Earnings Whispers
However, our proven model does not conclusively show that Patterson Companies is likely to beat earnings this quarter. That is because a stock needs to have both a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) for this to happen. That is not the case here as you will see below.
Zacks ESP: Patterson Companies currently has an Earnings ESP of -3.92%. This is because the Most Accurate estimate stands at 49 cents while the Zacks Consensus Estimate remains at 51 cents.
Zacks Rank: Patterson Companies currently carries a Zacks Rank #4 (Sell). Please note that we caution against stocks with a Zacks Rank #4 or 5 (Sell-rated) going into the earnings announcement, especially when the company is seeing negative estimate revision.
Stocks to Consider
Here are some companies you may want to consider as our model shows they have the right combination of elements to post an earnings beat this quarter:
Best Buy Co., Inc (BBY - Free Report) with an Earnings ESP of +4.76% and a Zacks Rank #3.
Ascendis Pharma A/S Inc. (ASND - Free Report) with an Earnings ESP of +7.46% and a Zacks Rank #2.
Broadcom Limited (AVGO - Free Report) with an Earnings ESP of +0.87% and a Zacks Rank #3.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>